https://www.openbell.ai/ 2026-10-07T17:42:44.013Z hourly 1.0 https://www.openbell.ai/support 2026-10-07T17:42:44.013Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-07T17:42:44.013Z monthly 0.5 https://www.openbell.ai/terms 2026-10-07T17:42:44.013Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-07T17:42:44.013Z hourly 0.8 https://www.openbell.ai/news/SNDK:1791394797683 2026-10-07T17:39:57.683Z daily 0.9 https://cdn.brandfetch.io/SNDK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sandisk Stock Is Surging Wednesday: What's Going On? Sandisk Corp. (NASDAQ: SNDK) saw its stock rise by over 4% on Wednesday, driven by increasing demand for AI-driven storage solutions and expectations of tighter NAND supply. Analysts predict that the memory industry will remain undersupplied through 2027, with NAND potentially becoming a major supply bottleneck. The company's upcoming earnings report is anticipated to show earnings of $46.13 per share on revenue of $10.63 billion, significantly up from the previous year. Sandisk shares are currently trading at $1,727.92. https://www.openbell.ai/news/MU:1791394787545 2026-10-07T17:39:47.545Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Micron Technology shares are trading higher after DA Davidson maintained its Buy rating on the stock and raised its price target from $2100 to $3000. openbell Financial News https://www.openbell.ai/news/AFL:1791394697186 2026-10-07T17:38:17.186Z daily 0.9 https://cdn.brandfetch.io/AFL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mizuho Maintains Underperform on Aflac, Lowers Price Target to $107 Mizuho analyst Yaron Kinar has maintained an 'Underperform' rating on Aflac (NYSE: AFL) and has lowered the price target from $116 to $107. This adjustment reflects the analyst's outlook on the company's performance. https://www.openbell.ai/news/MRVL:1791394692437 2026-10-07T17:38:12.437Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Marvell Stock Is Up 230% This Year: Bank of America Sees a Further 40% Upside Marvell Technology Inc. (NASDAQ: MRVL) has seen its stock price increase by approximately 233% this year, rising from $84.98 to around $283. Following an investor day, Bank of America analyst Vivek Arya maintained a Buy rating and raised the price target from $365 to $400, suggesting an additional 41% upside. Marvell aims for $80 billion in annual revenue by fiscal 2031, significantly higher than the Wall Street average of $43 billion, while also increasing its fiscal 2028 revenue target to nearly $20 billion, 10% above prior estimates. https://www.openbell.ai/news/NET:1791394523407 2026-10-07T17:35:23.407Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Solo--Indonesia---November-19--2025--The.jpg?width=250&height=187 Cloudflare Could Reach $800 Million Revenue in Q4, Analyst Says BTIG analyst Gray Powell has raised the price forecast for Cloudflare (NYSE: NET) from $382 to $413, maintaining a Buy rating, citing strong growth and product momentum. The company is projected to reach approximately $800 million in revenue for Q4, reflecting a 30.2% year-over-year increase. Year-to-date growth for the largest partner is reported at 40%-50%, with expectations for continued growth. Despite this, Cloudflare's stock is currently under selling pressure, down 1.77% to $348.72. https://www.openbell.ai/news/MSFT:1791394429780 2026-10-07T17:33:49.780Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Microsoft Exec Says Copilot Will Delegate Tasks To Local Models When Cost Or Privacy Are Key Concerns Microsoft's executive announced that the Copilot feature will leverage local models to handle tasks when cost or privacy concerns arise. This strategic move aims to enhance user experience by providing more control over data management. The announcement comes as part of Microsoft's ongoing efforts to improve its AI offerings and address customer needs. https://www.openbell.ai/news/PEP:1791394422844 2026-10-07T17:33:42.844Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Moscow--Russia-april-4--2014-Can-Of-Peps.jpg?width=250&height=187 PepsiCo Q3 Preview: Stock At Lowest Since 2020, Market Expert Sees 19% Downside On Weak Report PepsiCo is set to report its third-quarter earnings on Thursday, with analysts expecting revenue of $24.96 billion, an increase from $23.94 billion in the same quarter last year. The company has consistently beaten earnings estimates, with expected earnings per share of 88 cents, up from 82 cents. However, PepsiCo's stock is currently trading near seven-year lows, down 10.5% year-to-date, and analysts have lowered their price targets, indicating a potential 19% downside if the upcoming report is weak. https://www.openbell.ai/news/AAL:1791394328155 2026-10-07T17:32:08.155Z daily 0.9 https://cdn.brandfetch.io/AAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brazil Regulator Approves American Airlines' Proposed Acquisition Of Minority Stake In Azul Brazil's antitrust regulator, CADE, has approved American Airlines' proposed acquisition of a minority stake in Brazilian airline Azul. This strategic move is expected to enhance American Airlines' presence in the Brazilian market. The approval comes as part of an agreement that aims to foster cooperation between the two airlines. https://www.openbell.ai/news/DELL:1791394283886 2026-10-07T17:31:23.886Z daily 0.9 https://cdn.brandfetch.io/DELL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Dell Technologies; Hearing Investor Business Daily SwingTrader Buys Stock openbell Financial News https://www.openbell.ai/news/MSFT:1791393924750 2026-10-07T17:25:24.750Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Microsoft Rolls Out AI Coding Model That Can Run On Indivdual Laptops; New Nvidia Nemotron Model Will Run On Individual Laptops, PCs; OpenAI, Anthropic Will Adopt Microsoft Execution Containers For Agent Containment; Microsoft Execution Containers Will Work Across Windows, MacOS, Linux But Have Deeper Integration With Windows Microsoft has launched an AI coding model that can operate on individual laptops, enhancing accessibility for developers. Additionally, the new Nvidia Nemotron model will also be compatible with personal computers. OpenAI and Anthropic are set to adopt Microsoft Execution Containers for agent containment, which will be compatible across Windows, MacOS, and Linux, with a stronger integration for Windows systems. https://www.openbell.ai/news/HNGE:1791393747111 2026-10-07T17:22:27.111Z daily 0.9 https://cdn.brandfetch.io/HNGE/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Hinge Health Sees Hardware Deals Ahead in Digital Health Push'- Bloomberg Hinge Health is positioning itself for future hardware deals as part of its strategy to enhance its digital health offerings. The company aims to expand its product line and improve patient outcomes through innovative technology solutions. Specific financial figures or stock price movements were not disclosed in the article. https://www.openbell.ai/news/BFLY:1791393701029 2026-10-07T17:21:41.029Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Toronto--Canada---January-6-2026-Butterf.jpg?width=250&height=187 Butterfly Network Lands Multi-Year Bridge Neurotech Deal Butterfly Network Inc (NYSE: BFLY) has entered into a multi-year research and development agreement with Bridge Neurotech to create a non-invasive brain-computer interface utilizing ultrasound technology. The deal allows Bridge to license Butterfly's Ultrasound-on-Chip technology and includes specific payments for early access and development milestones. Following the announcement, Butterfly Network shares fell 5.27% to $8.24. This partnership is part of Butterfly's Embedded program, which has seen increased momentum with recent deals in brain-computer interfaces. https://www.openbell.ai/news/ZYME:1791393662662 2026-10-07T17:21:02.662Z daily 0.9 https://cdn.brandfetch.io/ZYME/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Zymeworks, Raises Price Target to $34 Truist Securities analyst Gregory Renza has maintained a Buy rating on Zymeworks (NASDAQ: ZYME) and increased the price target from $32 to $34. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/ZS:1791393612645 2026-10-07T17:20:12.645Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Reiterates Buy on Zscaler, Raises Price Target to $250 Truist Securities analyst Junaid Siddiqui has reiterated a Buy rating on Zscaler (NASDAQ: ZS) and increased the price target from $200 to $250. This adjustment reflects positive sentiment towards the company's performance and potential growth. https://www.openbell.ai/news/RCL:1791393597219 2026-10-07T17:19:57.219Z daily 0.9 https://cdn.brandfetch.io/RCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Morgan Stanley Selling Pieces of $3 Billion Royal Caribbean Loan' - Bloomberg Morgan Stanley is selling portions of a $3 billion loan to Royal Caribbean. This move comes as the investment bank seeks to offload its exposure to the cruise line amid ongoing market fluctuations. The loan is part of Royal Caribbean's financing strategy as it navigates recovery from the pandemic's impact on the travel industry. https://www.openbell.ai/news/BULL:1791393570897 2026-10-07T17:19:30.897Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Los-Angeles--California---July-11-2025-W.jpg?width=250&height=187 Webull Stock Just Lost 20%. Here Are the Next 3 Catalysts for BULL Webull Corporation (NASDAQ: BULL) experienced a significant selloff, losing approximately 20% of its stock value following a congressional report questioning its ties to China. Key upcoming events for investors include the annual general meeting on October 30, where management will address shareholder concerns, and the third-quarter earnings report on November 19, which will provide insights into the company's financial performance. Additionally, a law firm is investigating potential violations of federal securities laws related to Webull's disclosures, adding further uncertainty to the stock's outlook. https://www.openbell.ai/news/MSFT:1791393565888 2026-10-07T17:19:25.888Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Microsoft Rolls Out Microsoft Execution Containers To Block Agents From Unauthorized Data Access Microsoft has introduced Microsoft Execution Containers, a new security feature designed to prevent unauthorized data access by agents. This initiative aims to enhance data protection within its cloud services. The announcement reflects Microsoft's ongoing commitment to improving cybersecurity measures in response to increasing threats in the digital landscape. https://www.openbell.ai/news/SMCI:1791393489205 2026-10-07T17:18:09.205Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Supermicro-Logo.jpg?width=250&height=187 Why Is Super Micro Computer Stock Trading Higher Today? Super Micro Computer, Inc. (NASDAQ: SMCI) shares increased by approximately 2% to $44.36 following a Wall Street Journal report that AI data-center provider Lambda is raising $4 billion in a final funding round ahead of its planned IPO, valuing the company at $14.5 billion. This rise occurred despite a downturn in the broader Technology sector, with the Information Technology Select Sector SPDR Fund (XLK) down 0.50%. Super Micro's stock has gained over 50% in 2026, driven by demand for AI infrastructure and a growing order backlog, which increased from $15 billion in June to $50 billion in September 2026, largely due to a $35 billion commitment from Anthropic. https://www.openbell.ai/news/SM:1791393059090 2026-10-07T17:10:59.090Z daily 0.9 https://cdn.brandfetch.io/SM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on SM Energy, Raises Price Target to $48 Truist Securities analyst Gabe Daoud has maintained a 'Buy' rating on SM Energy (NYSE: SM) and raised the price target from $43 to $48. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/RVMD:1791392816762 2026-10-07T17:06:56.762Z daily 0.9 https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Revolution Medicines, Raises Price Target to $240 Truist Securities analyst Gregory Renza has maintained a 'Buy' rating on Revolution Medicines (NASDAQ: RVMD) and increased the price target from $239 to $240. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/REGN:1791392755411 2026-10-07T17:05:55.411Z daily 0.9 https://cdn.brandfetch.io/REGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $780 Truist Securities analyst Gregory Renza has maintained a Buy rating on Regeneron Pharmaceuticals (NASDAQ: REGN) and raised the price target from $772 to $780. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/MTEN:1791392745662 2026-10-07T17:05:45.662Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 11 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session On Wednesday, Mingteng International (NASDAQ: MTEN) saw its stock increase by 19.4% to $1.15, with a market cap of $7.3 million. Other notable gainers included LightInTheBox Holding (NYSE: LITB), which rose 9.64% to $3.07, and Gaotu Techedu (NYSE: GOTU), up 8.91% to $2.81, with market caps of $55.2 million and $656.1 million, respectively. Conversely, BrilliA (AMEX: BRIA) experienced the largest decline, falling 20.0% to $1.12, with a market cap of $35.0 million. https://www.openbell.ai/news/SXTC:1791392745419 2026-10-07T17:05:45.419Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Health Care Stocks Moving In Wednesday's Intraday Session On Wednesday, China SXT Pharmaceuticals (NASDAQ: SXTC) saw its shares surge by 186.0% to $3.58. Sunshine Biopharma (NASDAQ: SBFM) also experienced significant gains, rising 151.31% to $1.0, with a market cap of $1.5 million. Conversely, Caribou Biosciences (NASDAQ: CRBU) faced a sharp decline of 45.3%, dropping to $0.62, while SCWorx Corp (NASDAQ: WORX) fell by 33.8% to $4.8. https://www.openbell.ai/news/TOPP:1791392745201 2026-10-07T17:05:45.201Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Industrials Stocks Moving In Wednesday's Intraday Session On Wednesday, Toppoint Holdings (AMEX: TOPP) saw its shares rise by 62.8% to $0.18, with a market value of $2.7 million. Other notable gainers included Baiya International Group (NASDAQ: BIYA), which increased by 62.66% to $2.22, and Pinnacle Food Group (NASDAQ: PFAI), up 62.39% to $3.8, with market caps of $5.8 million and $27.5 million, respectively. Conversely, VCI Global (NASDAQ: VCIG) experienced a significant decline of 45.3%, dropping to $0.77, while HUHUTECH International Group (NASDAQ: HUHU) fell by 19.75% to $3.15, with a market cap of $101.6 million. https://www.openbell.ai/news/AMPGZ:1791392744983 2026-10-07T17:05:44.983Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Information Technology Stocks Moving In Wednesday's Intraday Session On Wednesday, Amplitech Group, Inc. (NASDAQ: AMPGZ) saw a significant increase of 44.0% in its share price, reaching $0.18. Other notable gainers included Z Squared (NASDAQ: ZSQR), which rose 22.01% to $5.32, and Cango (NYSE: CANG), up 17.21% to $3.54. Conversely, Socket Mobile (NASDAQ: SCKT) experienced the largest decline, with shares dropping 19.3% to $0.67, while XIAO-I (NASDAQ: AIXI) fell 18.38% to $1.51. https://www.openbell.ai/news/PFE:1791392723404 2026-10-07T17:05:23.404Z daily 0.9 https://cdn.brandfetch.io/PFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Pfizer’s TUKYSA Regimen Obtains FDA Approval As Front-Line Maintenance Treatment For HER2+ Metastatic Breast Cancer Pfizer Inc. (NYSE: PFE) has received FDA approval for TUKYSA (tucatinib) in combination with trastuzumab and pertuzumab as a front-line maintenance treatment for adults with unresectable locally advanced or metastatic HER2+ breast cancer. This approval is based on a study showing over 50% improvement in median progression-free survival, providing a new chemotherapy-free option for patients to delay disease progression. https://www.openbell.ai/news/CRWD:1791392647188 2026-10-07T17:04:07.188Z daily 0.9 https://cdn.brandfetch.io/CRWD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is CrowdStrike Stock Falling Wednesday? CrowdStrike Holdings Inc. (NASDAQ: CRWD) saw its stock decline by approximately 4% on Wednesday, attributed to broader market weakness affecting high-multiple technology stocks, with the Nasdaq down 0.44% and the S&P 500 down 0.35%. This pullback follows a record high of $286.99 reached just a day prior. Analysts expect CrowdStrike's upcoming earnings report on December 1 to show earnings of 31 cents per share and revenue of $1.51 billion, reflecting strong growth expectations despite the stock's high valuation. Currently, CrowdStrike shares are trading at $267.44. https://www.openbell.ai/news/RXO:1791392640843 2026-10-07T17:04:00.843Z daily 0.9 https://cdn.brandfetch.io/RXO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on RXO, Raises Price Target to $30 Truist Securities analyst Lucas Servera has maintained a Buy rating on RXO (NYSE: RXO) and raised the price target from $28 to $30. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/RCKT:1791392479988 2026-10-07T17:01:19.988Z daily 0.9 https://cdn.brandfetch.io/RCKT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Leerink Partners Maintains Market Perform on Rocket Pharmaceuticals, Lowers Price Target to $4 Leerink Partners analyst Roanna Ruiz has maintained a Market Perform rating on Rocket Pharmaceuticals (NASDAQ: RCKT) and has reduced the price target from $7 to $4. This adjustment reflects a more cautious outlook on the company's performance. https://www.openbell.ai/news/OABI:1791392380290 2026-10-07T16:59:40.290Z daily 0.9 https://cdn.brandfetch.io/OABI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Leerink Partners Maintains Outperform on OmniAb, Raises Price Target to $12 Leerink Partners analyst Puneet Souda has maintained an 'Outperform' rating on OmniAb (NASDAQ: OABI) and raised the price target from $10 to $12. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/MCK:1791392273233 2026-10-07T16:57:53.233Z daily 0.9 https://cdn.brandfetch.io/MCK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1070 Leerink Partners analyst Michael Cherny has maintained an Outperform rating on McKesson (NYSE: MCK) and raised the price target from $1030 to $1070. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/SPCX:1791392249802 2026-10-07T16:57:29.802Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud SpaceX shares are trading lower following reports suggesting the company is looking to issue $40 billion in new debt to buy Nvidia chips for its data centers. openbell Financial News https://www.openbell.ai/news/IWM:1791392017069 2026-10-07T16:53:37.069Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Stock-market-weakness.jpg?width=250&height=187 Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7% U.S. stocks experienced a decline on Wednesday, with the S&P 500 falling 0.4% to 7,788 and the Dow Jones Industrial Average dropping 0.9% to 51,056, primarily impacted by a 6.3% decrease in Caterpillar Inc. The Russell 2000 index underperformed, shedding 1.4% to 2,792. Treasury yields rose, with the 30-year yield reaching a 24-year high of 5.70%. The healthcare sector showed resilience, with the Health Care Select Sector SPDR Fund climbing 1.7%. https://www.openbell.ai/news/ZS:1791392002502 2026-10-07T16:53:22.502Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Maintains Sector Outperform on Zscaler, Raises Price Target to $255 Scotiabank analyst Patrick Colville has maintained a Sector Outperform rating on Zscaler (NASDAQ: ZS) and increased the price target from $240 to $255. https://www.openbell.ai/news/AEHR:1791391924500 2026-10-07T16:52:04.500Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/AehrRichmond--Virginia--Usa---8-May-2019.jpg?width=250&height=187 Aehr Test Systems Bags $6 Million Follow-On Order Aehr Test Systems (NASDAQ: AEHR) has secured approximately $6 million in follow-on production orders from its lead hyperscale customer for testing a next-generation AI processor. The orders will enhance testing capacity with additional Sonoma systems and are expected to be delivered over the next six months, coinciding with a production ramp anticipated in 2027. Despite this positive development, Aehr's stock fell about 5% to $87.63 amid a broader market pullback in high-risk technology stocks. https://www.openbell.ai/news/JAZZ:1791391803119 2026-10-07T16:50:03.119Z daily 0.9 https://cdn.brandfetch.io/JAZZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $286 Truist Securities analyst Gregory Renza has maintained a Buy rating on Jazz Pharmaceuticals (NASDAQ: JAZZ) and raised the price target from $281 to $286. This adjustment reflects positive sentiment towards the company's performance and market position. https://www.openbell.ai/news/RACE:1791391765481 2026-10-07T16:49:25.481Z daily 0.9 https://cdn.brandfetch.io/RACE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Sarat Sethi Announces Bought More Ferrari; Bought More Walt Disney Company openbell Financial News https://www.openbell.ai/news/GILD:1791391652382 2026-10-07T16:47:32.382Z daily 0.9 https://cdn.brandfetch.io/GILD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Gilead Sciences, Raises Price Target to $158 Truist Securities analyst Gregory Renza has maintained a Buy rating on Gilead Sciences (NASDAQ: GILD) and increased the price target from $150 to $158. This adjustment reflects positive sentiment towards the company's performance and future prospects. https://www.openbell.ai/news/SPCX:1791391625869 2026-10-07T16:47:05.869Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Kevin Simpson Announces Bought More SpaceX openbell Financial News https://www.openbell.ai/news/GMAB:1791391528067 2026-10-07T16:45:28.067Z daily 0.9 https://cdn.brandfetch.io/GMAB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Genmab, Raises Price Target to $45 Truist Securities analyst Asthika Goonewardene has maintained a Buy rating on Genmab (NASDAQ: GMAB) and raised the price target from $40 to $45. https://www.openbell.ai/news/SKYD:1791391357683 2026-10-07T16:42:37.683Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/An-Image-That-Combines-The-Logos-Of-Para.jpg?width=250&height=187 Skydance Stock Plummets: What's Going On? Skydance Corp (NYSE: SKYD) shares fell 7.87% to $8.77 following the completion of its acquisition of Warner Bros. Discovery, which closed on Tuesday. The deal, approved by competition authorities in nearly 70 jurisdictions, involved cash payments of approximately $31.02 per share to WBD shareholders. Skydance aims to achieve at least $6 billion in run-rate synergies within three years and plans to produce at least 30 theatrical films annually, despite concerns over its ability to manage approximately $80 billion in debt post-merger. https://www.openbell.ai/news/ZS:1791391338819 2026-10-07T16:42:18.819Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Zscaler, Raises Price Target to $245 JP Morgan analyst Brian Essex has maintained an Overweight rating on Zscaler (NASDAQ: ZS) and raised the price target from $215 to $245. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/MRVL:1791391259643 2026-10-07T16:40:59.643Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Marvell Technology, Raises Price Target to $360 JP Morgan analyst Harlan Sur has maintained an Overweight rating on Marvell Technology (NASDAQ: MRVL) and increased the price target from $305 to $360. This adjustment reflects a positive outlook for the company's performance. https://www.openbell.ai/news/LPLA:1791391164596 2026-10-07T16:39:24.596Z daily 0.9 https://cdn.brandfetch.io/LPLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on LPL Finl Hldgs, Raises Price Target to $445 JP Morgan analyst Michael Cho has maintained an Overweight rating on LPL Financial Holdings (NASDAQ: LPLA) and increased the price target from $428 to $445. https://www.openbell.ai/news/SPAI:1791391106111 2026-10-07T16:38:26.111Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Empty-Army-Command-Post-Used-For-Operati.jpg?width=250&height=187 Safe Pro Sees Revenue Exploding 2,300% As Defense Contracts Ramp Up Safe Pro Group Inc. (NASDAQ: SPAI) projected a third-quarter revenue of over $2.5 million, marking a 2,300% increase from $101,422 a year earlier, driven by new U.S. government contracts for its AI-powered technologies. For the first nine months of 2026, the company expects revenue to exceed $5 million, a growth of over 1,200% from the previous year. The company has secured over $5 million in government contracts this year and anticipates a sequential revenue increase of about 88% from the second quarter. Safe Pro's stock rose 4.15% to $4.26 following the announcement. https://www.openbell.ai/news/XLV:1791391071132 2026-10-07T16:37:51.132Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Stacked-Silver-Bars--Silver-Reserves--St.jpg?width=250&height=187 Silver Slides Below $60 as Yields Surge, Seasonal Liquidity Slump Materializes Silver prices fell below $60 an ounce, reaching a nine-week low, as U.S. Treasury yields surged to 5.36% for 10-year bonds and 5.72% for 30-year bonds, the highest since June 2002. This decline is exacerbated by a seasonal liquidity slump due to China's Golden Week holidays, which has reduced trading volumes. Deutsche Bank forecasts a shift from silver scarcity to surplus, predicting that silver-backed funds could release about 40 million ounces by December 2027, as inventories in London and CME warehouses have increased significantly. https://www.openbell.ai/news/GILD:1791390923225 2026-10-07T16:35:23.225Z daily 0.9 https://cdn.brandfetch.io/GILD/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Gilead Sciences, Raises Price Target to $170 JP Morgan analyst Chris Schott has maintained an Overweight rating on Gilead Sciences (NASDAQ: GILD) and raised the price target from $160 to $170. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/FCX:1791390856892 2026-10-07T16:34:16.892Z daily 0.9 https://cdn.brandfetch.io/FCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Freeport-McMoRan, Raises Price Target to $92 JP Morgan analyst Bill Peterson has maintained an Overweight rating on Freeport-McMoRan (NYSE: FCX) and raised the price target from $77 to $92. https://www.openbell.ai/news/FCEL:1791390851577 2026-10-07T16:34:11.577Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Stuttgart--Germany---09-08-2023-Person-H.jpg?width=250&height=187 FuelCell Energy Names New CFO, Reaffirms 2027 Profitability Target As AI Power Demand Builds FuelCell Energy, Inc. (NASDAQ: FCEL) has appointed Matthew Latino as its new CFO, effective October 7, succeeding Michael Bishop, who will remain as a senior advisor until the 2027 Annual Meeting. The company reaffirmed its target of achieving positive adjusted EBITDA in the fourth quarter of fiscal 2027, contingent on production rate increases and backlog conversions. In the third quarter of fiscal 2026, FuelCell reported revenue of $33.0 million, a 29% decrease from the previous year, and an adjusted EBITDA loss of $36.7 million, compared to a loss of $16.4 million a year earlier. https://www.openbell.ai/news/SVRA:1791390737608 2026-10-07T16:32:17.608Z daily 0.9 https://cdn.brandfetch.io/SVRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Savara with Overweight Rating, Announces Price Target of $12 JP Morgan analyst Caroline Pocher has initiated coverage on Savara (NASDAQ: SVRA) with an Overweight rating and set a price target of $12 for the stock. This marks a positive outlook for the company as it begins to attract analyst attention.